← 產業報告目錄
Transdermal Drug Delivery System Industry Research Report 2026
出版商 APO Research產業別 Healthcare & Life Sciences出版日期 2026-01-08頁數 131報告編號 APO-c3a5d8b78b
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.
Global Transdermal Drug Delivery System key players include Hisamitsu, Mylan, GSK, Novartis, Teve (Actavis), etc. Global top five manufacturers hold a share over 65%. North America is the largest market, with a share over 40%, followed by Europe and Asia-Pacific, both have a share over 45% percent.
In terms of product, Nitroglycerin is the largest segment, with a share over 25%. And in terms of application, the largest application is OTC, followed by RX.
Report Scope
This report quantifies the global Transdermal Drug Delivery System market in terms of revenue (US$ million) and, where applicable, service volume (M Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/M Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Transdermal Drug Delivery System.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Transdermal Drug Delivery System Market by Company
Hisamitsu
Mylan
GSK
Novartis
Teve (Actavis)
Johnson & Johnson
Lohmann
Teikoku Seiyaku
Bayer
Lingrui
Sanofi
Qizheng
Endo
Huarun 999
Haw Par
Nichiban
Mentholatum
Laboratoires Genevrier
Transdermal Drug Delivery System Segment by Type
Fentanyl
Nitroglycerin
Estradiol
Nicotine
Other
Transdermal Drug Delivery System Segment by Application
OTC
Rx
Transdermal Drug Delivery System Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Drug Delivery System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transdermal Drug Delivery System and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Drug Delivery System.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Transdermal Drug Delivery System companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Transdermal Drug Delivery System by Type
2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
2.2.2 Fentanyl
2.2.3 Nitroglycerin
2.2.4 Estradiol
2.2.5 Nicotine
2.2.6 Other
2.3 Transdermal Drug Delivery System by Application
2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.3.2 OTC
2.3.3 Rx
2.4 Assumptions and Limitations
3 Transdermal Drug Delivery System Breakdown Data by Type
3.1 Global Transdermal Drug Delivery System Historic Market Size by Type (2021-2026)
3.2 Global Transdermal Drug Delivery System Forecasted Market Size by Type (2027-2032)
4 Transdermal Drug Delivery System Breakdown Data by Application
4.1 Global Transdermal Drug Delivery System Historic Market Size by Application (2021-2026)
4.2 Global Transdermal Drug Delivery System Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
5.1 Global Transdermal Drug Delivery System Market Perspective (2021-2032)
5.2 Global Transdermal Drug Delivery System Growth Trends by Region
5.2.1 Global Transdermal Drug Delivery System Market Size by Region: 2021 VS 2025 VS 2032
5.2.2 Transdermal Drug Delivery System Historic Market Size by Region (2021-2026)
5.2.3 Transdermal Drug Delivery System Forecasted Market Size by Region (2027-2032)
5.3 Transdermal Drug Delivery System Market Dynamics
5.3.1 Transdermal Drug Delivery System Industry Trends
5.3.2 Transdermal Drug Delivery System Market Drivers
5.3.3 Transdermal Drug Delivery System Market Challenges
5.3.4 Transdermal Drug Delivery System Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Transdermal Drug Delivery System Players by Revenue
6.1.1 Global Top Transdermal Drug Delivery System Players by Revenue (2021-2026)
6.1.2 Global Transdermal Drug Delivery System Revenue Market Share by Players (2021-2026)
6.2 Global Transdermal Drug Delivery System Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of Transdermal Drug Delivery System Head Office and Area Served
6.4 Global Transdermal Drug Delivery System Players, Product Type & Application
6.5 Global Transdermal Drug Delivery System Manufacturers Established Date
6.6 Global Transdermal Drug Delivery System Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Transdermal Drug Delivery System Market Size (2021-2032)
7.2 North America Transdermal Drug Delivery System Market Growth Rate by Country: 2021 VS 2025 VS 2032
7.3 North America Transdermal Drug Delivery System Market Size by Country (2021-2026)
7.4 North America Transdermal Drug Delivery System Market Size by Country (2027-2032)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 Europe
8.1 Europe Transdermal Drug Delivery System Market Size (2021-2032)
8.2 Europe Transdermal Drug Delivery System Market Growth Rate by Country: 2021 VS 2025 VS 2032
8.3 Europe Transdermal Drug Delivery System Market Size by Country (2021-2026)
8.4 Europe Transdermal Drug Delivery System Market Size by Country (2027-2032)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Transdermal Drug Delivery System Market Size (2021-2032)
9.2 Asia-Pacific Transdermal Drug Delivery System Market Growth Rate by Country: 2021 VS 2025 VS 2032
9.3 Asia-Pacific Transdermal Drug Delivery System Market Size by Country (2021-2026)
9.4 Asia-Pacific Transdermal Drug Delivery System Market Size by Country (2027-2032)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 South America
10.1 South America Transdermal Drug Delivery System Market Size (2021-2032)
10.2 South America Transdermal Drug Delivery System Market Growth Rate by Country: 2021 VS 2025 VS 2032
10.3 South America Transdermal Drug Delivery System Market Size by Country (2021-2026)
10.4 South America Transdermal Drug Delivery System Market Size by Country (2027-2032)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 Middle East & Africa
11.1 Middle East & Africa Transdermal Drug Delivery System Market Size (2021-2032)
11.2 Middle East & Africa Transdermal Drug Delivery System Market Growth Rate by Country: 2021 VS 2025 VS 2032
11.3 Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2021-2026)
11.4 Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2027-2032)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 Players Profiled
12.1 Hisamitsu
12.1.1 Hisamitsu Company Information
12.1.2 Hisamitsu Business Overview
12.1.3 Hisamitsu Revenue in Transdermal Drug Delivery System Business (2021-2026)
12.1.4 Hisamitsu Transdermal Drug Delivery System Product Portfolio
12.1.5 Hisamitsu Recent Developments
12.2 Mylan
12.2.1 Mylan Company Information
12.2.2 Mylan Business Overview
12.2.3 Mylan Revenue in Transdermal Drug Delivery System Business (2021-2026)
12.2.4 Mylan Transdermal Drug Delivery System Product Portfolio
12.2.5 Mylan Recent Developments
12.3 GSK
12.3.1 GSK Company Information
12.3.2 GSK Business Overview
12.3.3 GSK Revenue in Transdermal Drug Delivery System Business (2021-2026)
12.3.4 GSK Transdermal Drug Delivery System Product Portfolio
12.3.5 GSK Recent Developments
12.4 Novartis
12.4.1 Novartis Company Information
12.4.2 Novartis Business Overview
12.4.3 Novartis Revenue in Transdermal Drug Delivery System Business (2021-2026)
12.4.4 Novartis Transdermal Drug Delivery System Product Portfolio
12.4.5 Novartis Recent Developments
12.5 Teve (Actavis)
12.5.1 Teve (Actavis) Company Information
12.5.2 Teve (Actavis) Business Overview
12.5.3 Teve (Actavis) Revenue in Transdermal Drug Delivery System Business (2021-2026)
12.5.4 Teve (Actavis) Transdermal Drug Delivery System Product Portfolio
12.5.5 Teve (Actavis) Recent Developments
12.6 Johnson & Johnson
12.6.1 Johnson & Johnson Company Information
12.6.2 Johnson & Johnson Business Overview
12.6.3 Johnson & Johnson Revenue in Transdermal Drug Delivery System Business (2021-2026)
12.6.4 Johnson & Johnson Transdermal Drug Delivery System Product Portfolio
12.6.5 Johnson & Johnson Recent Developments
12.7 Lohmann
12.7.1 Lohmann Company Information
12.7.2 Lohmann Business Overview
12.7.3 Lohmann Revenue in Transdermal Drug Delivery System Business (2021-2026)
12.7.4 Lohmann Transdermal Drug Delivery System Product Portfolio
12.7.5 Lohmann Recent Developments
12.8 Teikoku Seiyaku
12.8.1 Teikoku Seiyaku Company Information
12.8.2 Teikoku Seiyaku Business Overview
12.8.3 Teikoku Seiyaku Revenue in Transdermal Drug Delivery System Business (2021-2026)
12.8.4 Teikoku Seiyaku Transdermal Drug Delivery System Product Portfolio
12.8.5 Teikoku Seiyaku Recent Developments
12.9 Bayer
12.9.1 Bayer Company Information
12.9.2 Bayer Business Overview
12.9.3 Bayer Revenue in Transdermal Drug Delivery System Business (2021-2026)
12.9.4 Bayer Transdermal Drug Delivery System Product Portfolio
12.9.5 Bayer Recent Developments
12.10 Lingrui
12.10.1 Lingrui Company Information
12.10.2 Lingrui Business Overview
12.10.3 Lingrui Revenue in Transdermal Drug Delivery System Business (2021-2026)
12.10.4 Lingrui Transdermal Drug Delivery System Product Portfolio
12.10.5 Lingrui Recent Developments
12.11 Sanofi
12.11.1 Sanofi Company Information
12.11.2 Sanofi Business Overview
12.11.3 Sanofi Revenue in Transdermal Drug Delivery System Business (2021-2026)
12.11.4 Sanofi Transdermal Drug Delivery System Product Portfolio
12.11.5 Sanofi Recent Developments
12.12 Qizheng
12.12.1 Qizheng Company Information
12.12.2 Qizheng Business Overview
12.12.3 Qizheng Revenue in Transdermal Drug Delivery System Business (2021-2026)
12.12.4 Qizheng Transdermal Drug Delivery System Product Portfolio
12.12.5 Qizheng Recent Developments
12.13 Endo
12.13.1 Endo Company Information
12.13.2 Endo Business Overview
12.13.3 Endo Revenue in Transdermal Drug Delivery System Business (2021-2026)
12.13.4 Endo Transdermal Drug Delivery System Product Portfolio
12.13.5 Endo Recent Developments
12.14 Huarun 999
12.14.1 Huarun 999 Company Information
12.14.2 Huarun 999 Business Overview
12.14.3 Huarun 999 Revenue in Transdermal Drug Delivery System Business (2021-2026)
12.14.4 Huarun 999 Transdermal Drug Delivery System Product Portfolio
12.14.5 Huarun 999 Recent Developments
12.15 Haw Par
12.15.1 Haw Par Company Information
12.15.2 Haw Par Business Overview
12.15.3 Haw Par Revenue in Transdermal Drug Delivery System Business (2021-2026)
12.15.4 Haw Par Transdermal Drug Delivery System Product Portfolio
12.15.5 Haw Par Recent Developments
12.16 Nichiban
12.16.1 Nichiban Company Information
12.16.2 Nichiban Business Overview
12.16.3 Nichiban Revenue in Transdermal Drug Delivery System Business (2021-2026)
12.16.4 Nichiban Transdermal Drug Delivery System Product Portfolio
12.16.5 Nichiban Recent Developments
12.17 Mentholatum
12.17.1 Mentholatum Company Information
12.17.2 Mentholatum Business Overview
12.17.3 Mentholatum Revenue in Transdermal Drug Delivery System Business (2021-2026)
12.17.4 Mentholatum Transdermal Drug Delivery System Product Portfolio
12.17.5 Mentholatum Recent Developments
12.18 Laboratoires Genevrier
12.18.1 Laboratoires Genevrier Company Information
12.18.2 Laboratoires Genevrier Business Overview
12.18.3 Laboratoires Genevrier Revenue in Transdermal Drug Delivery System Business (2021-2026)
12.18.4 Laboratoires Genevrier Transdermal Drug Delivery System Product Portfolio
12.18.5 Laboratoires Genevrier Recent Developments
13 Report Conclusion
14 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Transdermal Drug Delivery System Market Size by Type (2021-2026) & (US$ Million)
Table 6. Global Transdermal Drug Delivery System Revenue Market Share by Type (2021-2026)
Table 7. Global Transdermal Drug Delivery System Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 8. Global Transdermal Drug Delivery System Revenue Market Share by Type (2027-2032)
Table 9. Global Transdermal Drug Delivery System Market Size by Application (2021-2026) & (US$ Million)
Table 10. Global Transdermal Drug Delivery System Revenue Market Share by Application (2021-2026)
Table 11. Global Transdermal Drug Delivery System Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 12. Global Transdermal Drug Delivery System Revenue Market Share by Application (2027-2032)
Table 13. Global Transdermal Drug Delivery System Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 14. Global Transdermal Drug Delivery System Market Size by Region (2021-2026) & (US$ Million)
Table 15. Global Transdermal Drug Delivery System Market Share by Region (2021-2026)
Table 16. Global Transdermal Drug Delivery System Forecasted Market Size by Region (2027-2032) & (US$ Million)
Table 17. Global Transdermal Drug Delivery System Market Share by Region (2027-2032)
Table 18. Transdermal Drug Delivery System Industry Trends
Table 19. Transdermal Drug Delivery System Industry Drivers
Table 20. Transdermal Drug Delivery System Industry Opportunities and Challenges
Table 21. Transdermal Drug Delivery System Market Restraints
Table 22. Global Top Transdermal Drug Delivery System Players by Revenue (US$ Million) & (2021-2026)
Table 23. Global Transdermal Drug Delivery System Revenue Market Share by Players (2021-2026)
Table 24. Global Transdermal Drug Delivery System Industry Players Ranking, 2024 VS 2025 VS 2026
Table 25. Global Key Players of Transdermal Drug Delivery System, Headquarters and Area Served
Table 26. Global Transdermal Drug Delivery System Players, Product Type & Application
Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
Table 28. Global Transdermal Drug Delivery System by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 29. Players Mergers & Acquisitions, Expansion Plans
Table 30. North America Transdermal Drug Delivery System Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 31. North America Transdermal Drug Delivery System Market Size by Country (2021-2026) & (US$ Million)
Table 32. North America Transdermal Drug Delivery System Market Size by Country (2027-2032) & (US$ Million)
Table 33. Europe Transdermal Drug Delivery System Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Europe Transdermal Drug Delivery System Market Size by Country (2021-2026) & (US$ Million)
Table 35. Europe Transdermal Drug Delivery System Market Size by Country (2027-2032) & (US$ Million)
Table 36. Asia Pacific Transdermal Drug Delivery System Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Asia Pacific Transdermal Drug Delivery System Market Size by Region (2021-2026) & (US$ Million)
Table 38. Asia Pacific Transdermal Drug Delivery System Market Size by Country (2027-2032) & (US$ Million)
Table 39. South America Transdermal Drug Delivery System Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 40. South America Transdermal Drug Delivery System Market Size by Country (2021-2026) & (US$ Million)
Table 41. South America Transdermal Drug Delivery System Market Size by Country (2027-2032) & (US$ Million)
Table 42. Middle East & Africa Transdermal Drug Delivery System Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 43. Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2027-2032) & (US$ Million)
Table 45. Hisamitsu Company Information
Table 46. Hisamitsu Business Overview
Table 47. Hisamitsu Revenue in Transdermal Drug Delivery System Business (2021-2026) & (US$ Million)
Table 48. Hisamitsu Transdermal Drug Delivery System Product Portfolio
Table 49. Hisamitsu Recent Developments
Table 50. Mylan Company Information
Table 51. Mylan Business Overview
Table 52. Mylan Revenue in Transdermal Drug Delivery System Business (2021-2026) & (US$ Million)
Table 53. Mylan Transdermal Drug Delivery System Product Portfolio
Table 54. Mylan Recent Developments
Table 55. GSK Company Information
Table 56. GSK Business Overview
Table 57. GSK Revenue in Transdermal Drug Delivery System Business (2021-2026) & (US$ Million)
Table 58. GSK Transdermal Drug Delivery System Product Portfolio
Table 59. GSK Recent Developments
Table 60. Novartis Company Information
Table 61. Novartis Business Overview
Table 62. Novartis Revenue in Transdermal Drug Delivery System Business (2021-2026) & (US$ Million)
Table 63. Novartis Transdermal Drug Delivery System Product Portfolio
Table 64. Novartis Recent Developments
Table 65. Teve (Actavis) Company Information
Table 66. Teve (Actavis) Business Overview
Table 67. Teve (Actavis) Revenue in Transdermal Drug Delivery System Business (2021-2026) & (US$ Million)
Table 68. Teve (Actavis) Transdermal Drug Delivery System Product Portfolio
Table 69. Teve (Actavis) Recent Developments
Table 70. Johnson & Johnson Company Information
Table 71. Johnson & Johnson Business Overview
Table 72. Johnson & Johnson Revenue in Transdermal Drug Delivery System Business (2021-2026) & (US$ Million)
Table 73. Johnson & Johnson Transdermal Drug Delivery System Product Portfolio
Table 74. Johnson & Johnson Recent Developments
Table 75. Lohmann Company Information
Table 76. Lohmann Business Overview
Table 77. Lohmann Revenue in Transdermal Drug Delivery System Business (2021-2026) & (US$ Million)
Table 78. Lohmann Transdermal Drug Delivery System Product Portfolio
Table 79. Lohmann Recent Developments
Table 80. Teikoku Seiyaku Company Information
Table 81. Teikoku Seiyaku Business Overview
Table 82. Teikoku Seiyaku Revenue in Transdermal Drug Delivery System Business (2021-2026) & (US$ Million)
Table 83. Teikoku Seiyaku Transdermal Drug Delivery System Product Portfolio
Table 84. Teikoku Seiyaku Recent Developments
Table 85. Bayer Company Information
Table 86. Bayer Business Overview
Table 87. Bayer Revenue in Transdermal Drug Delivery System Business (2021-2026) & (US$ Million)
Table 88. Bayer Transdermal Drug Delivery System Product Portfolio
Table 89. Bayer Recent Developments
Table 90. Lingrui Company Information
Table 91. Lingrui Business Overview
Table 92. Lingrui Revenue in Transdermal Drug Delivery System Business (2021-2026) & (US$ Million)
Table 93. Lingrui Transdermal Drug Delivery System Product Portfolio
Table 94. Lingrui Recent Developments
Table 95. Sanofi Company Information
Table 96. Sanofi Business Overview
Table 97. Sanofi Revenue in Transdermal Drug Delivery System Business (2021-2026) & (US$ Million)
Table 98. Sanofi Transdermal Drug Delivery System Product Portfolio
Table 99. Sanofi Recent Developments
Table 100. Qizheng Company Information
Table 101. Qizheng Business Overview
Table 102. Qizheng Revenue in Transdermal Drug Delivery System Business (2021-2026) & (US$ Million)
Table 103. Qizheng Transdermal Drug Delivery System Product Portfolio
Table 104. Qizheng Recent Developments
Table 105. Endo Company Information
Table 106. Endo Business Overview
Table 107. Endo Revenue in Transdermal Drug Delivery System Business (2021-2026) & (US$ Million)
Table 108. Endo Transdermal Drug Delivery System Product Portfolio
Table 109. Endo Recent Developments
Table 110. Huarun 999 Company Information
Table 111. Huarun 999 Business Overview
Table 112. Huarun 999 Revenue in Transdermal Drug Delivery System Business (2021-2026) & (US$ Million)
Table 113. Huarun 999 Transdermal Drug Delivery System Product Portfolio
Table 114. Huarun 999 Recent Developments
Table 115. Haw Par Company Information
Table 116. Haw Par Business Overview
Table 117. Haw Par Revenue in Transdermal Drug Delivery System Business (2021-2026) & (US$ Million)
Table 118. Haw Par Transdermal Drug Delivery System Product Portfolio
Table 119. Haw Par Recent Developments
Table 120. Nichiban Company Information
Table 121. Nichiban Business Overview
Table 122. Nichiban Revenue in Transdermal Drug Delivery System Business (2021-2026) & (US$ Million)
Table 123. Nichiban Transdermal Drug Delivery System Product Portfolio
Table 124. Nichiban Recent Developments
Table 125. Mentholatum Company Information
Table 126. Mentholatum Business Overview
Table 127. Mentholatum Revenue in Transdermal Drug Delivery System Business (2021-2026) & (US$ Million)
Table 128. Mentholatum Transdermal Drug Delivery System Product Portfolio
Table 129. Mentholatum Recent Developments
Table 130. Laboratoires Genevrier Company Information
Table 131. Laboratoires Genevrier Business Overview
Table 132. Laboratoires Genevrier Revenue in Transdermal Drug Delivery System Business (2021-2026) & (US$ Million)
Table 133. Laboratoires Genevrier Transdermal Drug Delivery System Product Portfolio
Table 134. Laboratoires Genevrier Recent Developments
Table 135. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Transdermal Drug Delivery System Product Image
Figure 5. Global Transdermal Drug Delivery System Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 6. Global Transdermal Drug Delivery System Market Share by Type: 2025 VS 2032
Figure 7. Fentanyl Product
Figure 8. Nitroglycerin Product
Figure 9. Estradiol Product
Figure 10. Nicotine Product
Figure 11. Other Product
Figure 12. Global Transdermal Drug Delivery System Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 13. Global Transdermal Drug Delivery System Market Share by Application: 2025 VS 2032
Figure 14. OTC Product
Figure 15. Rx Product
Figure 16. Global Transdermal Drug Delivery System Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 17. Global Transdermal Drug Delivery System Market Size, (US$ Million), 2021 VS 2025 VS 2032
Figure 18. Global Transdermal Drug Delivery System Market Share by Region: 2025 VS 2032
Figure 19. Global Transdermal Drug Delivery System Market Share by Players in 2025
Figure 20. Global Transdermal Drug Delivery System Manufacturers Established Date
Figure 21. Global Top 5 and 10 Transdermal Drug Delivery System Players Market Share by Revenue in 2025
Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 23. North America Transdermal Drug Delivery System Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 24. North America Transdermal Drug Delivery System Market Share by Country (2021-2032)
Figure 25. United States Transdermal Drug Delivery System Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 26. Canada Transdermal Drug Delivery System Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 27. Mexico Transdermal Drug Delivery System Market Share by Country (2021-2032)
Figure 28. Europe Transdermal Drug Delivery System Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 29. Europe Transdermal Drug Delivery System Market Share by Country (2021-2032)
Figure 30. Germany Transdermal Drug Delivery System Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 31. France Transdermal Drug Delivery System Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 32. U.K. Transdermal Drug Delivery System Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 33. Italy Transdermal Drug Delivery System Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 34. Spain Transdermal Drug Delivery System Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 35. Russia Transdermal Drug Delivery System Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 36. Netherlands Transdermal Drug Delivery System Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 37. Nordic Countries Transdermal Drug Delivery System Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 38. Asia-Pacific Transdermal Drug Delivery System Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 39. Asia-Pacific Transdermal Drug Delivery System Market Share by Country (2021-2032)
Figure 40. China Transdermal Drug Delivery System Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 41. Japan Transdermal Drug Delivery System Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 42. South Korea Transdermal Drug Delivery System Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 43. India Transdermal Drug Delivery System Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 44. India Transdermal Drug Delivery System Market Share by Country (2021-2032)
Figure 45. Australia Transdermal Drug Delivery System Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 46. China Taiwan Transdermal Drug Delivery System Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 47. Southeast Asia Transdermal Drug Delivery System Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 48. South America Transdermal Drug Delivery System Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 49. South America Transdermal Drug Delivery System Market Share by Country (2021-2032)
Figure 50. Brazil Transdermal Drug Delivery System Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 51. Argentina Transdermal Drug Delivery System Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 52. Chile Transdermal Drug Delivery System Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 53. Colombia Transdermal Drug Delivery System Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 54. Peru Transdermal Drug Delivery System Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 55. Hisamitsu Revenue Growth Rate in Transdermal Drug Delivery System Business (2021-2026)
Figure 56. Mylan Revenue Growth Rate in Transdermal Drug Delivery System Business (2021-2026)
Figure 57. GSK Revenue Growth Rate in Transdermal Drug Delivery System Business (2021-2026)
Figure 58. Novartis Revenue Growth Rate in Transdermal Drug Delivery System Business (2021-2026)
Figure 59. Teve (Actavis) Revenue Growth Rate in Transdermal Drug Delivery System Business (2021-2026)
Figure 60. Johnson & Johnson Revenue Growth Rate in Transdermal Drug Delivery System Business (2021-2026)
Figure 61. Lohmann Revenue Growth Rate in Transdermal Drug Delivery System Business (2021-2026)
Figure 62. Teikoku Seiyaku Revenue Growth Rate in Transdermal Drug Delivery System Business (2021-2026)
Figure 63. Bayer Revenue Growth Rate in Transdermal Drug Delivery System Business (2021-2026)
Figure 64. Lingrui Revenue Growth Rate in Transdermal Drug Delivery System Business (2021-2026)
Figure 65. Sanofi Revenue Growth Rate in Transdermal Drug Delivery System Business (2021-2026)
Figure 66. Qizheng Revenue Growth Rate in Transdermal Drug Delivery System Business (2021-2026)
Figure 67. Endo Revenue Growth Rate in Transdermal Drug Delivery System Business (2021-2026)
Figure 68. Huarun 999 Revenue Growth Rate in Transdermal Drug Delivery System Business (2021-2026)
Figure 69. Haw Par Revenue Growth Rate in Transdermal Drug Delivery System Business (2021-2026)
Figure 70. Nichiban Revenue Growth Rate in Transdermal Drug Delivery System Business (2021-2026)
Figure 71. Mentholatum Revenue Growth Rate in Transdermal Drug Delivery System Business (2021-2026)
Figure 72. Laboratoires Genevrier Revenue Growth Rate in Transdermal Drug Delivery System Business (2021-2026)
提及公司
HisamitsuMylanGSKNovartisTeve (Actavis)Johnson & JohnsonLohmannTeikoku SeiyakuBayerLingruiSanofiQizhengEndoHuarun 999Haw ParNichibanMentholatumLaboratoires Genevrier
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們